Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice
Study Identifier
HUM 03-1
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
Observation of safety, tolerability and effectiveness of adalimumab (Humira) therapy in a large patient collective under everyday clinical conditions over a 5-year period.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 35034
Aachen, Germany, 52062
Status
Not applicable
Location
Site Reference ID/Investigator# 35033
Aachen, Germany, 52064
Status
Not applicable
Location
Site Reference ID/Investigator# 53919
Achern, Germany, 77855
Status
Not applicable
Location
Site Reference ID/Investigator# 53883
Aichhalden, Germany, 78733
Status
Not applicable
Location
Site Reference ID/Investigator# 35041
Altenburg, Germany, 04600
Status
Not applicable
Location
Site Reference ID/Investigator# 35050
Amberg, Germany, 92224
Status
Not applicable
Showing {first} - {last} of {total} Results